Pregnancy-Associated Breast Cancer: An analytical observational study

被引:5
作者
Baulies, Sonia [1 ]
Cusido, Maite [1 ]
Tresserra, Francisco [2 ]
Rodriguez, Ignacio [3 ]
Ubeda, Belen [4 ]
Ara, Carmen [1 ]
Fabregas, Rafael [1 ]
机构
[1] Inst Univ Dexeus, Dept Obstet Ginecol & Reprod Humana, Unidad Ginecol Oncol & Mastol, Barcelona, Spain
[2] Inst Univ Dexeus, Dept Anat Patol, Barcelona, Spain
[3] Inst Univ Dexeus, Dept Obstet Ginecol & Reprod Humana, Unidad Epidemiol & Estadist, Barcelona, Spain
[4] Inst Univ Dexeus, Dept Obstet Ginecol & Reprod Humana, Unidad Diagnost Ginecol Imagen, Barcelona, Spain
来源
MEDICINA CLINICA | 2014年 / 142卷 / 05期
关键词
Breast cancer; Pregnancy; Prognostic factors; Management; CARCINOMA; CHEMOTHERAPY; WOMEN; MANAGEMENT; OUTCOMES; RISK;
D O I
10.1016/j.medcli.2012.12.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Pregnancy-associated breast cancer is defined as breast cancer diagnosed during pregnancy and up to one year postpartum. Patients and method: A retrospective, analytical, observational study comparing 56 cases of breast cancer and pregnancy (PABC) diagnosed 1976-2008 with 73 patients with breast cancer not associated with pregnancy (non-PABC) was performed. Demographic data, prognostic factors, treatment and survival were reviewed and compared. Results: The prevalence of PABC in our center is 8.3/10,000. The highest frequency (62%) appeared during the postpartum period. The stages are higher in PABC, being 31.3% advanced (EIII and EIV) in PABC versus 13.3% in non-PABC (P <.05). Regarding prognostic factors, 27.3% in PABC had a tumoral grade 3 versus 15.8% of non-PABC. Among women with PABC, 33.3% had negative estrogen receptors, 48.7% negative progesterone receptors and 34.5% positive Her2Neu compared with 22.2, 24.1 and 31%, respectively of non-PABC patients. Finally, positive lymph nodes were found in 52.8% of PABC, versus 33.8% non-PABC (P <.05). Overall and disease-free survival rate at 5 years for PABC was 63.7 and 74.2%, respectively. Conclusions: The poorer survival observed is possibly due to the presence of adverse prognostic features. such as lymph node metastases, negative hormone receptors, tumoral grade is, as well as a delay in diagnosis with a higher rate of advanced stages. (C) 2012 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:200 / 204
页数:5
相关论文
共 27 条
[21]   Chemotherapy for breast cancer during pregnancy: An 18-year experience from five London teaching hospitals [J].
Ring, AE ;
Smith, IE ;
Jones, A ;
Shannon, C ;
Galani, E ;
Ellis, PA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4192-4197
[22]   Evidence of poorer survival in pregnancy-associated breast cancer [J].
Rodriguez, Anne O. ;
Chew, Helen ;
Cress, Rosemary ;
Xing, Guibo ;
McElvy, Sherrie ;
Danielsen, Beate ;
Smith, Lloyd .
OBSTETRICS AND GYNECOLOGY, 2008, 112 (01) :71-78
[23]   Breast Cancer in Pregnancy [J].
Rovera, Francesca ;
Frattini, Francesco ;
Coglitore, Alessandra ;
Marelli, Marina ;
Rausei, Stefano ;
Dionigi, Gianlorenzo ;
Boni, Luigi ;
Dionigi, Renzo .
BREAST JOURNAL, 2010, 16 :S22-S25
[24]   Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast, April 19-22, 2001, Philadelphia, Pennsylvania [J].
Schwartz, GF ;
Giuliano, AE ;
Veronesi, U .
CANCER, 2002, 94 (10) :2542-2551
[25]  
Smith BL, 1996, CURR PROB OBST GYN F, V19, P5
[26]   Management of breast cancer in pregnancy [J].
Theriault R. ;
Hahn K. .
Current Oncology Reports, 2007, 9 (1) :17-21
[27]   PHARMACOLOGY OF ANTINEOPLASTIC AGENTS IN PREGNANCY [J].
WIEBE, VJ ;
SIPILA, PEH .
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1994, 16 (02) :75-112